BioSpace News Archive

Deals

U.S. Asset Manager Wants in On China Biotech Unicorn Innovent Biologics’ $200M+ IPO

The Suzhou-based cancer-drug maker has been discussing a valuation of more than $1 billion.

January 15, 2018
·
1 min read
Hua Medicine to Raise $200M to Support Novel Diabetes Drug

Hua Medicine of Shanghai expects to spend $200M over the next three years on its novel oral diabetes 2 treatment, dorzagliatin.

January 15, 2018
·
1 min read
Biotech Bay

3 Biopharmas Worth Watching in 2018

Here are three biopharma stocks worth keeping an eye on.

January 15, 2018
·
2 min read
·
Mark Terry
Policy

Struggling Teva Gets Another Hit, Fined for Foreign Bribes

The fine was over Teva paying bribes to foreign officials to win business in Russia, Ukraine and Mexico, the ministry said.

January 15, 2018
·
1 min read
Drug Development

Why 2018 Could be Alnylam’s Best Year Yet

Some achievements are hard to top.

January 15, 2018
·
1 min read
BioMidwest

Boston Scientific, Medtronic Show Off Neuromodulation Devices Trial Data

The companies announced the data as an industry conference in Las Vegas.

January 15, 2018
·
1 min read
Business

Alnylam CEO Calls Out Trump’s Alleged Immigration Remarks

This not the first time Maraganore has tweeted his support for the benefits of immigration.

January 15, 2018
·
3 min read
·
Alex Keown
Policy

Woman Sues Bayer After Essure Device Leaves Her in Constant Pain

The mom of three is now the seventh Scottish woman to join a group legal action against Bayer.

January 15, 2018
·
1 min read
FDA

Following FDA Approval for PAD, Ra Medical Steps Up Hiring

Ra Medical only has five full-time salespeople on staff, but expects that to grow to 20 to 25 people later this year.

January 15, 2018
·
3 min read
·
Alex Keown
BioMidwest

The Top 6 Global Generic Drug Companies to Work For

Here’s a look at the top six generic drug companies to work for.

January 15, 2018
·
5 min read
·
Mark Terry